ANNOVIS BIO ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

(marketscreener.com) BERWYN, Pa., April 3, 2023 /PRNewswire/ -- Annovis Bio, Inc.  , a clinical-stage drug platform company addressing neurodegenerative diseases, has announced fourth quarter and full year financial results for the period ended December 31, 2022, and reviewed recent accomplishments. ...https://www.marketscreener.com/quote/stock/ANNOVIS-BIO-INC-102588345/news/ANNOVIS-BIO-ANNOUNCES-FOURTH-QUARTER-AND-FULL-YEAR-2022-FINANCIAL-RESULTS-AND-PROVIDES-CORPORATE-UPD-43414190/?utm_medium=RSS&utm_content=20230403